PD-Rx Pharmaceuticals, Inc. (PDRX)

OTCMKTS · Delayed Price · Currency is USD
2.760
+0.010 (0.36%)
At close: Apr 16, 2025
-49.82%
Market Cap 4.54M
Revenue (ttm) 18.95M
Net Income (ttm) -753.50K
Shares Out 1.64M
EPS (ttm) -0.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 700
Average Volume 1,927
Open 2.760
Previous Close 2.750
Day's Range 2.760 - 2.760
52-Week Range 2.500 - 5.500
Beta 1,210,140.13
RSI 39.18
Earnings Date Dec 6, 2024

About PD-Rx Pharmaceuticals

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, including creams, ointments, ophthalmics, otics, liquids, and suspensions products. It also provides packaging services. In addition, the company offers dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as handling package; and PD-Rx Net, a web-based application designed to track... [Read more]

Sector Healthcare
Founded 1986
Employees 28
Stock Exchange OTCMKTS
Ticker Symbol PDRX
Full Company Profile

Financial Performance

In 2024, PD-Rx Pharmaceuticals's revenue was $18.95 million, a decrease of -10.93% compared to the previous year's $21.27 million. Losses were -$753,495, 668.4% more than in 2023.

Financial Statements

News

There is no news available yet.